Alexander Stein - Dissemin

Language
Login

All papers authored by Alexander Stein

This paper was not found in any repository, but could be made available legally by the author.

2021 Jean Bourhis, Alexander Stein

ORCID

, Jan Paul de Boer, Marc Van Den Eynde, Kathryn A. Gold, Sebastian Stintzing

ORCID

, Jürgen C. Becker, Michael Moran, Andreas Schroeder

ORCID

, Gregory Pennock, Satu Salmio, Regina Esser, Fortunato Ciardiello

Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Hans-Joachim Schmoll

ORCID

, Murielle E. Mauer, Sandrine Marreaud, Alexander Stein

ORCID

Reply to P. Potemski and K. Bujko

Upload

This paper is made freely available by the publisher.

2020 Hans-Joachim Schmoll

ORCID

, Alexander Stein

ORCID

, Eric Van Cutsem, Timothy Price, Ralf D. Hofheinz, Bernard Nordlinger, Jean-François Daisne, Jos Janssens, Baruch Brenner, Hans Reinel, Stephan Hollerbach, Karel Caca, Florian Fauth, Carla V. Hannig, John Zalcberg

ORCID

and 5 other authors

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

Download from doi.org

This paper is made freely available by the publisher.

Viktor Grünwald

ORCID

, Annika Karch, Markus Schuler, Patrick Schöffski, Hans-Georg Kopp, Sebastian Bauer

ORCID

ORCID

, Lars H. Lindner, Jens-Marcus Chemnitz, Martina Crysandt, Alexander Stein

ORCID

, Björn Steffen, Stephan Richter, Gerlinde Egerer, Philipp Ivanyi

ORCID

and 3 other authors

Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

Download from doi.org

This paper is made freely available by the publisher.

Joseph Tintelnot

ORCID

, Eray Goekkurt, Mascha Binder, Peter Thuss-Patience, Sylvie Lorenzen, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Thomas Ettrich, Udo Lindig, Lutz Jacobasch, Daniel Pink, Salah-Eddin Al-Batran, Axel Hinke, Susanna Hegewisch-Becker, Sven Nilsson and 2 other authors

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)

Download from link.springer.com

Missing publications? Search for publications with a matching author name.